In the last 12 months, insiders at Citius Pharmaceuticals, Inc. ($CTXR) filed 37 transactions with the SEC: 0 open-market purchases totaling $0 and 0 sales totaling $0. Net insider sentiment: neutral.
Citius Pharmaceuticals, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Webb Carol (Director) — 4 transactions totaling $362
- Holuka Eugene Myron (Director) — 4 transactions totaling $72
- HOLUBIAK MYRON Z (Vice Chairman) — 12 transactions totaling $0
- Dutia Suren G (Director) — 1 transaction totaling $0
- Smith Robert Joseph (Director) — 2 transactions totaling $0
View all SEC Filings for Citius Pharmaceuticals, Inc. (CTXR).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug. 8, 2025 | Mazur Leonard L | Chief Executive Officer | A | Warrant to Purchase Common Stock | 89388 | $0.00 | 89,388.0000 | 11,006,896 | 9999.99% | 0.81% |
| Aug. 8, 2025 | Mazur Leonard L | Chief Executive Officer | D | Warrant to Purchase Common Stock | 89388 | $0.00 | 0.0000 | 11,006,896 | 100.00% | 0.81% |
| Aug. 8, 2025 | Mazur Leonard L | Chief Executive Officer | A | Warrant to Purchase Common Stock | 125490 | $0.00 | 125,490.0000 | 11,006,896 | 9999.99% | 1.14% |
| Aug. 8, 2025 | Mazur Leonard L | Chief Executive Officer | D | Warrant to Purchase Common Stock | 125490 | $0.00 | 0.0000 | 11,006,896 | 100.00% | 1.14% |
| Aug. 8, 2025 | HOLUBIAK MYRON Z | Vice Chairman | D | Warrant to Purchase Common Stock | 31373 | $0.00 | 0.0000 | 11,006,896 | 100.00% | 0.29% |
| Aug. 8, 2025 | HOLUBIAK MYRON Z | Vice Chairman | A | Warrant to Purchase Common Stock | 31373 | $0.00 | 31,373.0000 | 11,006,896 | 9999.99% | 0.29% |
| Aug. 8, 2025 | HOLUBIAK MYRON Z | Vice Chairman | D | Warrant to Purchase Common Stock | 22344 | $0.00 | 0.0000 | 11,006,896 | 100.00% | 0.20% |
| Aug. 8, 2025 | HOLUBIAK MYRON Z | Vice Chairman | A | Warrant to Purchase Common Stock | 22344 | $0.00 | 22,344.0000 | 11,006,896 | 9999.99% | 0.20% |
| Nov. 7, 2024 | Czuczman Myron | Chief Medical Officer | A | Stock Option (Right to Purchase Common Stock) | 300000 | $0.00 | 1,700,000.0000 | 6,726,999 | 21.43% | 4.46% |
| Nov. 7, 2024 | Dutia Suren G | Director | A | Stock Option (Right to Purchase Common Stock) | 125000 | $0.00 | 526,667.0000 | 6,726,999 | 31.12% | 1.86% |
| Nov. 7, 2024 | MCGRATH DENNIS M | Director | A | Stock Option (Right to Purchase Common Stock) | 125000 | $0.00 | 275,000.0000 | 6,726,999 | 83.33% | 1.86% |
| Nov. 7, 2024 | HOLUBIAK MYRON Z | Vice Chairman | A | Stock Option (Right to Purchase Common Stock) | 350000 | $0.00 | 2,716,667.0000 | 6,726,999 | 14.79% | 5.20% |
| Nov. 7, 2024 | HOLUBIAK MYRON Z | Vice Chairman | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 6,726,999 | 9999.99% | 1.11% |
| Nov. 7, 2024 | Holuka Eugene Myron | Director | A | Stock Option (Right to Purchase Common Stock) | 125000 | $0.00 | 513,334.0000 | 6,726,999 | 32.19% | 1.86% |
| Nov. 7, 2024 | Mazur Leonard L | Chief Executive Officer | A | Stock Option (Right to Purchase Common Stock) | 600000 | $0.00 | 3,215,000.0000 | 6,726,999 | 22.94% | 8.92% |
| Nov. 7, 2024 | Bartushak Jaime | Chief Financial Officer | A | Stock Option (Right to Purchase Common Stock) | 350000 | $0.00 | 1,718,267.0000 | 6,726,999 | 25.58% | 5.20% |
| Nov. 7, 2024 | Smith Robert Joseph | Director | A | Stock Option (Right to Purchase Common Stock) | 125000 | $0.00 | 200,000.0000 | 6,726,999 | 166.67% | 1.86% |
| Nov. 7, 2024 | Webb Carol | Director | A | Stock Option (Right to Purchase Common Stock) | 125000 | $0.00 | 513,334.0000 | 6,726,999 | 32.19% | 1.86% |
| Aug. 14, 2024 | Mazur Leonard L | Chief Executive Officer | D | Warrant to Purchase Common Stock | 3137255 | $0.00 | 1,165,048.0000 | 6,954,278 | 72.92% | 45.11% |
| Aug. 14, 2024 | Mazur Leonard L | Chief Executive Officer | A | Warrant to Purchase Common Stock | 3137255 | $0.00 | 4,302,303.0000 | 6,954,278 | 269.28% | 45.11% |
| Sept. 25, 2024 | Mazur Leonard L | Chief Executive Officer | D | Warrant to Purchase Common Stock | 2234700 | $0.00 | 1,165,048.0000 | 6,954,278 | 65.73% | 32.13% |
| Sept. 25, 2024 | Mazur Leonard L | Chief Executive Officer | A | Warrant to Purchase Common Stock | 2234700 | $0.00 | 3,399,748.0000 | 6,954,278 | 191.81% | 32.13% |
| Aug. 14, 2024 | HOLUBIAK MYRON Z | Vice Chairman | D | Warrant to Purchase Common Stock | 784314 | $0.00 | 129,450.0000 | 6,954,278 | 85.83% | 11.28% |
| Aug. 14, 2024 | HOLUBIAK MYRON Z | Vice Chairman | A | Warrant to Purchase Common Stock | 784314 | $0.00 | 913,764.0000 | 6,954,278 | 605.88% | 11.28% |
| Sept. 25, 2024 | HOLUBIAK MYRON Z | Vice Chairman | D | Warrant to Purchase Common Stock | 558597 | $0.00 | 129,450.0000 | 6,954,278 | 81.19% | 8.03% |
| Sept. 25, 2024 | HOLUBIAK MYRON Z | Vice Chairman | A | Warrant to Purchase Common Stock | 558597 | $0.00 | 688,047.0000 | 6,954,278 | 431.52% | 8.03% |
| March 4, 2024 | Webb Carol | Director | F | Common Stock | 236 | $0.77 | 11,835.0000 | 6,358,237 | 1.96% | 0.00% |
| March 4, 2024 | Webb Carol | Director | M | Stock Option (Right to Purchase Common Stock) | 12071 | $0.00 | 388,334.0000 | 6,358,237 | 3.01% | 0.19% |
| March 13, 2024 | Holuka Eugene Myron | Director | M | Common Stock | 2415 | $0.02 | 2,415.0000 | 6,358,237 | 9999.99% | 0.04% |
| March 13, 2024 | Holuka Eugene Myron | Director | F | Common Stock | 48 | $0.75 | 2,367.0000 | 6,358,237 | 1.99% | 0.00% |
| March 13, 2024 | Holuka Eugene Myron | Director | M | Stock Option (Right to Purchase Common Stock) | 2415 | $0.00 | 388,334.0000 | 6,358,237 | 0.62% | 0.04% |
| March 4, 2024 | Webb Carol | Director | M | Common Stock | 12071 | $0.02 | 12,071.0000 | 6,358,237 | 9999.99% | 0.19% |
| April 3, 2024 | Mazur Leonard L | Chief Executive Officer | D | Warrant to Purchase Common Stock | 1165048 | $0.00 | 5,371,955.0000 | 6,362,890 | 17.82% | 18.31% |
| April 3, 2024 | Mazur Leonard L | Chief Executive Officer | A | Warrant to Purchase Common Stock | 1165048 | $0.00 | 6,537,003.0000 | 6,362,890 | 21.69% | 18.31% |
| April 3, 2024 | HOLUBIAK MYRON Z | Vice Chairman | D | Warrant to Purchase Common Stock | 129450 | $0.00 | 1,342,911.0000 | 6,362,890 | 8.79% | 2.03% |
| April 3, 2024 | HOLUBIAK MYRON Z | Vice Chairman | A | Warrant to Purchase Common Stock | 129450 | $0.00 | 1,472,361.0000 | 6,362,890 | 9.64% | 2.03% |
| March 14, 2024 | Smith Robert Joseph | Director | A | Stock Option (Right to Purchase Common Stock) | 75000 | $0.00 | 75,000.0000 | 6,358,237 | 9999.99% | 1.18% |